DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Iodophenyl is an investigational drug.
There have been 9 clinical trials for Iodophenyl. The most recent clinical trial was a Phase 2 trial, which was initiated on July 12th 2017.
The most common disease conditions in clinical trials are Parkinson Disease, Colorectal Neoplasms, and Glioma. The leading clinical trial sponsors are Cellectar Biosciences, Inc., Anders Fink-Jensen, MD, DMSci, and Molecular Insight Pharmaceuticals, Inc.
Recent Clinical Trials for Iodophenyl
|Trametinib and TAS-102 in Treating Patients With Colon or Rectal Cancer That is Advanced, Metastatic, or Cannot Be Removed by Surgery||City of Hope Medical Center||Phase 1|
|Does Treatment With GLP-1 Reduce Alcohol Intake in Patients With Alcohol Dependence?||Neurobiology Research Unit, Rigshospitalet, Copenhagen||Phase 2|
|Does Treatment With GLP-1 Reduce Alcohol Intake in Patients With Alcohol Dependence?||Section of Biostatistics University of Copenhagen, Copenhagen||Phase 2|